Skip to main content
Top

Clinical Oncology and Cancer Research

Issue 3/2007

Content (14 Articles)

Role of TGF-β1 and its receptors in breast carcinogenesis: Evaluation of gene expression patterns and clinical implications

Wenjing Wang, Aesun Shin, Qiuyin Cai, Zefang Ren, Xiao-Ou Shu, Yutang Gao, Harold I. Moses, Wei Lu, Wei Zheng

Diagnosis and surgical treatment of 105 cases with a tumor of the chest wall

Qiming Xu, Naikang Zhou, Ying Liu, Chengxiu Yang

Multi-analysis of non-thyrogenous masses of the neck

Yong Li, Ming Gao, Yang Yu, Yigong Li, Yan Zhang, Xiaolong Li

Clinical significance of lymph node sampling in endometrial carcinoma

Ping Bai, Min Cheng, Shumin Li, Wenhua Zhang, Ying Ma

Retrospective study of Castleman’s disease: A report of fourteen cases and review of the literature

Waiyi Zou, Huixia Lan, Chang Su, Yunxian Chen, Juan Li, Shaokai Luo

Bladder paraganglioma with a calculus: A case report

Jian Wang, Hong Wu, Zhou Wu, Jianjun Liu

Prostatic foamy adenocarcinoma: A case report

Ming Han, Yangru Zong, Renjie Gong, Jing Qiu, Zhibin Liu, Boyong Hu, Bing Yao

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine